Diversion of duodenal contents: its effect on the production of experimental gastric cancer.
Diversion of duodenal contents after gastroenterostomy and vagotomy did not protect 240 laboratory rats from increased risk of gastric carcinoma. They were divided into three groups of 80: group 1 received 0.9 mg of 3-methylcholanthrene injected submucosally into the gastric antrum; groups 2 and 3 had bilateral truncal vagotomy and gastroenterostomy, with carcinogen injected into the gastric submucosa near the anastomosis; group 3 also had total duodenoenteric diversion. Blind histopathologic examination of surviving rats during necropsy eight months later disclosed that cancer had developed in six of 60 (10%) group 1 rats, in 23 of 71 (33%) group 2 rats, and in seven of 27 (22%) group 3 rats. Compared with group 1, groups 2 and 3 had an increased incidence of gastric cancer but did not differ from one another in this regard.
D000230:Adenocarcinoma / Q000453:epidemiology / Q000209:etiology*; D000818:Animals; D004386:Duodenum / Q000378:metabolism*; D005753:Gastric Mucosa / Q000473:pathology; D005763:Gastroenterostomy / Q000009:adverse effects*; D008297:Male; D008679:Metaplasia; D008748:Methylcholanthrene; D009374:Neoplasms, Experimental / Q000453:epidemiology / Q000209:etiology; D051381:Rats; D012306:Risk; D013274:Stomach Neoplasms / Q000453:epidemiology / Q000209:etiology*; D014628:Vagotomy / Q000009:adverse effects*
D008748:Methylcholanthrene